Persistent abdominal symptoms in US adults after short-term stay in Mexico

Journal of Travel Medicine

Volumn 21, Issue 3, 2014, Pages 153-158

  Nair, Parvathy ^a   Okhuysen, Pablo C ^a,b,c   Jiang, Zhi Dong ^a   Carlin, Lily G ^b   Belkind Gerson, Jaime ^a,d,e   Flores, Jose ^a   Paredes, Mercedes ^a   Dupont, Herbert L ^a,b,c,f  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f CHI ST LUKE S HEALTH BAYLOR ST LUKE S MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL CRAMP; ABDOMINAL DISEASE; ABDOMINAL DISTENSION; ABDOMINAL PAIN; ACUTE DIARRHEA; ADULT; AFRICAN AMERICAN; ARTICLE; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; BLOATING; CAUCASIAN; CONSTIPATION; CONTROLLED STUDY; CRYPTOSPORIDIUM; DEFECATION HABIT; ENTEROAGGREGATIVE ESCHERICHIA COLI; ENTEROTOXIGENIC ESCHERICHIA COLI; FECES ANALYSIS; FEMALE; FOLLOW UP; FUNCTIONAL ABDOMINAL DISORDER; GASTROINTESTINAL SYMPTOM; GENETIC ASSOCIATION; HISPANIC; HOST PATHOGEN INTERACTION; HUMAN; INFECTIOUS COMPLICATION; INTESTINE INFECTION; IRRITABLE COLON; LENGTH OF STAY; LOOSE FECES; MAJOR CLINICAL STUDY; MALE; MEXICO; NAUSEA; NONHUMAN; PROVIDENCIA; SALMONELLA; TENESMUS; TRAVELLER DIARRHEA; ADOLESCENT; COMPLICATION; DIARRHEA; EPIDEMIOLOGY; ESCHERICHIA COLI; IRRITABLE BOWEL SYNDROME; ISOLATION AND PURIFICATION; MICROBIOLOGY; ONSET AGE; PATHOPHYSIOLOGY; RISK ASSESSMENT; STATISTICS AND NUMERICAL DATA; SYMPTOM ASSESSMENT; TIME; TRAVEL; UNITED STATES;

ADOLESCENT; ADULT; AGE OF ONSET; DIARRHEA; ESCHERICHIA COLI; FEMALE; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MEXICO; PROVIDENCIA; RISK ASSESSMENT; SYMPTOM ASSESSMENT; TIME FACTORS; TRAVEL; UNITED STATES;

EID: 84898800643     PISSN: 11951982     EISSN: 17088305     Source Type: Journal    
DOI: 10.1111/jtm.12114     Document Type: Article

References (33)

1. Drossman DA, Camilleri M, Mayer EA, et al. AGA technical review on irritable bowel syndrome. Gastroenterology 2002; 123: 2108-2131.
2. Porter CK, Faix DJ, Shiau D, et al. Postinfectious gastrointestinal disorders following norovirus outbreaks. Clin Infect Dis 2012; 55: 915-922.
3. Dunlop SP, Jenkins D, Spiller RC,. Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome. Am J Gastroenterol 2003; 98: 1578-1583.
4. Spiller RC,. Role of infection in irritable bowel syndrome. J Gastroenterol 2007; 42 (Suppl 17): 41-47.
5. DuPont HL, Galler G, Garcia-Torres F, et al. Travel and travelers' diarrhea in patients with irritable bowel syndrome. Am J Trop Med Hyg 2010; 82: 301-305.
6. Jiang ZD, Lowe B, Verenkar MP, et al. Prevalence of enteric pathogens among international travelers with diarrhea acquired in Kenya (Mombasa), India (Goa), or Jamaica (Montego Bay). J Infect Dis 2002; 185: 497-502.
7. Jiang ZD, Mathewson JJ, Ericsson CD, et al. Characterization of enterotoxigenic Escherichia coli strains in patients with travelers' diarrhea acquired in Guadalajara, Mexico, 1992-1997. J Infect Dis 2000; 181: 779-782.
8. Adachi JA, Jiang ZD, Mathewson JJ, et al. Enteroaggregative Escherichia coli as a major etiologic agent in traveler's diarrhea in 3 regions of the world. Clin Infect Dis 2001; 32: 1706-1709.
9. DuPont HL, Ericsson CD,. Prevention and treatment of traveler's diarrhea. N Engl J Med 1993; 328: 1821-1827.
10. Okhuysen PC, Jiang ZD, Carlin L, et al. Post-diarrhea chronic intestinal symptoms and irritable bowel syndrome in North American travelers to Mexico. Am J Gastroenterol 2004; 99: 1774-1778.
11. Tuteja AK, Talley NJ, Gelman SS, et al. Development of functional diarrhea, constipation, irritable bowel syndrome, and dyspepsia during and after traveling outside the USA. Dig Dis Sci 2008; 53: 271-276.
12. Halvorson HA, Schlett CD, Riddle MS,. Postinfectious irritable bowel syndrome-a meta-analysis. Am J Gastroenterol 2006; 101: 1894-1899.
13. Gwee KA, Graham JC, McKendrick MW, et al. Psychometric scores and persistence of irritable bowel after infectious diarrhoea. Lancet 1996; 347: 150-153.
14. Neal KR, Hebden J, Spiller R,. Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients. BMJ 1997; 314: 779-782.
15. Thornley JP, Jenkins D, Neal K, et al. Relationship of Campylobacter toxigenicity in vitro to the development of postinfectious irritable bowel syndrome. J Infect Dis 2001; 184: 606-609.
16. Spiller RC,. Infection as a cause of irritable bowel syndrome. Hosp Med 2003; 64: 270-274.
17. Ji S, Park H, Lee D, et al. Postinfectious irritable bowel syndrome in patients with Shigella infection. J Gastroenterol Hepatol 2005; 20: 381-386.
18. Wang LH, Fang XC, Pan GZ,. Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis. Gut 2004; 53: 1096-1101.
19. Gwee KA, Collins SM, Read NW, et al. Increased rectal mucosal expression of interleukin 1beta in recently acquired postinfectious irritable bowel syndrome. Gut 2003; 52: 523-526.
20. Liebregts T, Adam B, Bredack C, et al. Immune activation in patients with irritable bowel syndrome. Gastroenterology 2007; 132: 913-920.
21. O'Sullivan M, Clayton N, Breslin NP, et al. Increased mast cells in the irritable bowel syndrome. Neurogastroenterol Motil 2000; 12: 449-457.
22. Spiller RC, Jenkins D, Thornley JP, et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 2000; 47: 804-811.
23. Koide A, Yamaguchi T, Odaka T, et al. Quantitative analysis of bowel gas using plain abdominal radiograph in patients with irritable bowel syndrome. Am J Gastroenterol 2000; 95: 1735-1741.
24. Lin HC,. Small intestinal bacterial overgrowth: a framework for understanding irritable bowel syndrome. JAMA 2004; 292: 852-858.
25. Pimentel M, Lin HC, Enayati P, et al. Methane, a gas produced by enteric bacteria, slows intestinal transit and augments small intestinal contractile activity. Am J Physiol Gastrointest Liver Physiol 2006; 290: G1089-G1095.
26. Barbara G, Stanghellini V, De Giorgio R, et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 2004; 126: 693-702.
27. Weston AP, Biddle WL, Bhatia PS, Miner PB Jr,. Terminal ileal mucosal mast cells in irritable bowel syndrome. Dig Dis Sci 1993; 38: 1590-1595.
28. Bearcroft CP, Perrett D, Farthing MJ,. Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study. Gut 1998; 42: 42-46.
29. Camilleri M, Andrews CN, Bharucha AE, et al. Alterations in expression of p11 and SERT in mucosal biopsy specimens of patients with irritable bowel syndrome. Gastroenterology 2007; 132: 17-25.
30. Collins SM, McHugh K, Jacobson K, et al. Previous inflammation alters the response of the rat colon to stress. Gastroenterology 1996; 111: 1509-1515.
31. Drossman DA, Creed FH, Olden KW, et al. Psychosocial aspects of the functional gastrointestinal disorders. Gut 1999; 45 (Suppl 2): II25-II30.
32. Dunlop SP, Jenkins D, Spiller RC,. Age-related decline in rectal mucosal lymphocytes and mast cells. Eur J Gastroenterol Hepatol 2004; 16: 1011-1015.
33. DuPont HL, Ericsson CD, Farthing MJ, et al. Expert review of the evidence base for prevention of travelers' diarrhea. J Travel Med 2009; 16: 149-160.